Physician profile
Carson C Cunningham
NPI 1861477218
$8,898.32
in general payments reported to CMS, 2019-2025
33 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,404 · 2020: $3,092 · 2021: $342 · 2022: $1,635 · 2023: $287 · 2024: $1,945 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,032 · Travel and Lodging: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.95 |
| Travel and Lodging | $393.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,414.62 | 2020-2024 | |
| W. L. Gore & Associates, INC. | $922.21 | 2021-2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial |
| Medical Device Business Services, INC. | $824.06 | 2019 | |
| Ethicon US, LLC | $676.86 | 2019-2024 | Echelon Flex, Ethicon |
| Davol INC. | $294.66 | 2022-2023 | Phasix Mesh, Arista Ah Flexitip |
| Medtronic, INC. | $185.51 | 2021 | |
| Boston Scientific Corporation | $180.17 | 2022-2025 | Spyglass Discover |
| Zimmer Biomet Holdings, INC. | $137.58 | 2022 | |
| Abbvie INC. | $123.90 | 2019-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $121.46 | 2019 | |
| Covidien Lp | $120.42 | 2019-2020 | |
| Solventum Corporation | $103.40 | 2024-2025 | Activ.A.C., V.A.C.Instill |
| Reprise Biomedical, INC. | $94.05 | 2023 | Mirotract, Miro3d, Miro3d Fibers |
| Polynovo North America LLC | $77.20 | 2024 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $70.33 | 2024 | Exparel |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $60.36 | 2024 | |
| Z-Medica, LLC | $57.37 | 2019 | |
| Acera Surgical, INC. | $55.22 | 2024 | Restrata Wound Matrix |
| Fujifilm Healthcare Americas Corporation | $54.77 | 2025 | |
| Micro-Tech Endoscopy USA, INC. | $50.00 | 2023 | Dat Closure Device |
| Kci USA, INC. | $46.75 | 2022-2023 | V.A.C. Veraflo |
| Takeda Pharmaceuticals U.S.A., INC. | $38.55 | 2022-2023 | Gattex |
| Baudax Bio INC. | $22.76 | 2021 | |
| Merck Sharp & Dohme LLC | $21.87 | 2025 | Keytruda |
| Integra Lifesciences Corporation | $21.59 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $20.29 | 2019 | |
| Baxter Healthcare | $19.17 | 2022 | |
| Myriad Genetic Laboratories, INC. | $17.97 | 2022 | |
| Tela Bio, INC. | $16.36 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Heron Therapeutics, INC. | $13.82 | 2021 | |
| Allergan, INC. | $12.18 | 2022 | |
| Medela LLC | $11.92 | 2021 | |
| Endo Pharmaceuticals INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.